RxDoctor Payments Data

Juliana Ruff, PA

Physician Assistant · Dallas, TXNPI 1912544875

Payments from drug & device makers

$2,052in general payments, 2019–2025

Across 106 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$619
  • AstraZeneca$325
  • Johnson & Johnson$180
  • Pfizer$149
  • Idorsia Pharmaceuticals US Inc$79
  • Astellas Pharma US Inc$76
  • plus $624 from 18 others

What the payments were for

  • Food & beverage$2,052100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,052 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$57,435
Medicare patients
313
Services billed
869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol23$23,671
EliquisApixaban17$23,652
OzempicSemaglutide17$19,195
JardianceEmpagliflozin12$19,030
Atorvastatin Calcium126$1,674
Fluticasone Propionate58$1,304
Ipratropium Bromide48$1,136
Azelastine-FluticasoneAzelastine/Fluticasone11$1,056
Lisinopril93$1,003
Losartan Potassium95$939
Rosuvastatin Calcium71$927
Pravastatin Sodium39$727
Amlodipine Besylate105$652
Simvastatin47$634
Gabapentin19$579

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$325$23,67123 claims
PfizerEliquis$149$23,65217 claims
Novo NordiskOzempic$619$19,19517 claims
Boehringer IngelheimJardiance$22$19,03012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →